on Blueberries Medical Corp. (CVE:BBM)
Blueberries Medical Finalizes C$1.1 Million Private Placement
Blueberries Medical Corp., a Toronto-based company focused on cannabis derivatives, announced the closing of a C$1.1 million non-brokered private placement. The placement, involving 84,615,385 common shares at C$0.013 per share, aims to fund operation expansions and general corporate purposes.
The investment was led by Terraflos Inc., chaired by Facundo Garreton, also Blueberries' CEO. Through this offering, Mr. Garreton's shares increased to 396,326,486, representing approximately 67.98% of the company's common shares.
The transaction was classified as a "related party transaction" but was exempt from requiring minority approval. The funds are earmarked to boost Blueberries' offerings and scale its operations in Latin America.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Blueberries Medical Corp. news